Released Mar 28, 2012, after the close
10-K filed Mar 28, 2012, 88 days after period end · 0001193125-12-137599
Q4 2011 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$1.59M$1.59M derivedno prior Q4 2010 on fileN/M vs Q3 2011
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Cash Flowderived-$4,169,000N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Net Income | $1.59M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR